NeuroEM
Curated by SignalHead worn device to prevent and treat Alzheimer's Disease with electromagnetic waves
Overview
NeuroEM Therapeutics is developing a self contained head device to prevent and treat Alzheimer's Disease with electromagnetic waves. Their TEMT technology achieves this by reversing brain Aβ aggregation. The company claims that their technology is the only Alzheimer's disease treatment modalityc shown to prevent and reverse Aβ aggregation both inside and outside neurons. The TEMT is an investigational device currently under development and not commercially available. As of July 2016, it has been tested in animals and has shown no adverse effects. Homan trials are yet to begin.
Key facts
- Founded
- 2013
- Headquarters
- Phoenix, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Business model
- 1 product or service
- Sign up to view
- Commercial model
- Sign up to view